Observational studyJournal of the American Heart Association2025

Comparative Outcomes of Glucagon-Like Peptide-1 Receptor Agonists to Dipeptidyl Peptidase 4 Inhibitors in Patients With Heart Failure and Type 2 Diabetes.

Takefumi Kishimori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.